Yet, HER2 overexpression in HER2 low‐expressing GC cell lines had limited effects on YTHDF1 protein and mRNA expression levels, probably due to the absence of additional activation of the HER2 downstream signaling pathway, as indicated by minimal changes in ERK and AKT phosphorylation (Figure 8F,G). Here, ERBB2 is linked to gastric cancer.